ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
2 stories in the last 7 days
The latest biotech news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks biotech across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Insilico's AI-driven IPF candidate Rentosertib shows potential for biological age reversal, according to six proteomic aging clocks. The company announcement, covered in Nature Biotechnology, highlights the drug's effect on aging biomarkers. Rentosertib targets idiopathic pulmonary fibrosis while demonstrating anti-aging properties.
A biotech company reported that an AI-discovered drug reversed aging markers in a study. The findings were announced by the company, which has not yet disclosed the drug's name or specific trial details.
Summaries by ByteBrief